This drug assists in the enhancement of glycemic regulation in adult patients who have a high level of hyperbolic acid (HBA1c) and/or are co-infected with other conditions. It will be priced at Rs 14 per tablet (per day).
Glenmark launches triple drug formulation for type 2 diabetes patients in India financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
Glenmark Pharma is first to launch a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 Diabetes in Adults with Co-morbidities equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Glenmark Pharma brings triple-drug FDC for type 2 diabetes in adults with co-morbidities biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.